Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro is not recommended for use while trying to conceive. Current UK guidance advises women to stop tirzepatide before attempting pregnancy, and to use effective contraception throughout treatment. If you are actively trying for a baby, that is one of the clearest reasons to pause Mounjaro and discuss your next steps with a prescriber. This is a question our clinical team hears regularly, and the honest answer is straightforward: the timing matters, and planning ahead makes a real difference.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: you've been on Mounjaro for several months, your weight has shifted in a way you haven't managed before, and now a pregnancy is moving from a vague plan to an active one. It's a genuinely common moment to arrive at, and it raises a question that deserves a clear answer rather than vague reassurance.
Tirzepatide has not been studied in human pregnancy. The absence of safety data isn't a technicality; it means nobody knows what the drug does to a developing embryo, and the precautionary position taken by UK regulators and manufacturers is that it should not be used by anyone trying to get pregnant. That position is firm. The NHS England weight-management injections guidance is explicit: effective contraception is required throughout treatment, and Mounjaro should be stopped ahead of any attempt to conceive.
What 'ahead of' means in practice is a question for your prescriber, because wash-out periods depend on how the drug clears your system and your individual circumstances. Don't rely on a forum estimate. A quick check of the patient information leaflet that came with your pen will confirm the manufacturer's stated guidance, and a conversation with your prescribing clinician will tell you what it means for your timeline specifically.
There is a layer to this that catches many women off guard. If you are using an oral contraceptive pill while taking Mounjaro, the drug's effect on gastric emptying can reduce how reliably the pill is absorbed. UK clinical guidance (as documented by NHS Inform Scotland) specifically advises adding a non-oral barrier method such as condoms for the first four weeks of Mounjaro treatment and for four weeks after every dose increase.
This matters in both directions. If you are trying to avoid pregnancy while on Mounjaro, relying on the pill alone at those moments is riskier than it would otherwise be. And if you are about to stop contraception because you want to try for a baby, the sequencing of stopping Mounjaro first becomes even more important.
For anyone using Mounjaro for weight management, this interaction is worth raising at your next clinical review. It is not a reason to panic, but it is a reason to plan. You can do one useful thing right now: pull out the information leaflet from your current Mounjaro pen and read the contraception section, it takes under a minute and the language is plain.
Stopping a treatment that has been working is understandably difficult to contemplate. Weight loss achieved on tirzepatide can support fertility, cycles can regularise, hormonal profiles can improve, and the physical demands of a healthy pregnancy become easier to meet at a lower weight. So there is real logic to having used Mounjaro as part of preconception preparation, even if it cannot continue once you are actively trying.
The key is a managed stop rather than an abrupt one. Some weight does return after stopping any GLP-1 medicine; how much, and how quickly, varies. A prescriber can help you think through the right moment to stop, what to expect, and whether any lifestyle adjustments would help you hold as much of your progress as possible through the preconception and pregnancy period. Our clinical team approach this as a planning conversation, not a dead end.
If you have been reading about Mounjaro and fertility more broadly, the picture is actually more nuanced than a simple 'stop immediately' message, timing, duration of wash-out, and your personal health history all feed into what the right plan looks like for you.
The not-recommended position applies whether you are actively trying to conceive right now or planning to in the next few months. It also applies regardless of dose: there is no lower tirzepatide dose that carries a green light in this context. Pregnancy, breastfeeding, and the preconception period all sit outside the licensed use of Mounjaro.
Beyond the conception question, there are other situations where Mounjaro needs careful clinical thought, kidney function and thyroid history are two that come up in consultations regularly. If you want to understand the full picture of how Mounjaro fits your individual circumstances, including what happens once you stop it ahead of trying to conceive, a prescriber review is the right next step. You can find answers to broader questions on our FAQs page, or explore weight management treatment options if your plans have changed.
When you're ready to talk it through, start your free consultation and a GPhC-registered prescriber will review your situation the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.